miR-320a induces pancreatic β cells dysfunction in diabetes by inhibiting MafF

Area of Science:

• Endocrinology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) play roles in diabetes pathogenesis.
• The specific function of miR-320a in pancreatic beta cells during diabetes mellitus is not fully understood.

Purpose of the Study:

• To investigate the direct role of miR-320a in the pathophysiology of pancreatic beta cells in diabetes mellitus.
• To identify the molecular mechanisms underlying miR-320a's effects on beta cells.

Main Methods:

• Utilized miR-320a transgenic mice with islet transplantation and hyperglycemic clamp assays.
• Employed adeno-associated virus (AAV8) for beta cell-specific miR-320a modulation in vivo.
• Conducted in vitro studies using INS1 cells with miR-320a overexpression or inhibition.
• Performed RNA immunoprecipitation sequencing (RIP-Seq), luciferase reporter assays, and western blotting to identify target genes.

Main Results:

• miR-320a levels were elevated in pancreatic beta cells of high-fat-diet (HFD)-induced diabetic mice.
• Overexpression of miR-320a worsened HFD-induced islet dysfunction and spontaneously caused islet dysfunction in vivo.
• In vitro, miR-320a increased reactive oxygen species (ROS) levels, inhibited proliferation, and induced apoptosis in beta cells.
• MafF was identified as a direct target of miR-320a, mediating beta cell dysfunction.

Conclusions:

• miR-320a directly damages pancreatic beta cells and contributes to diabetes pathophysiology.
• MafF is a key mediator of miR-320a-induced beta cell dysfunction.
• miR-320a represents a potential therapeutic target for managing diabetes mellitus.